VOR
Vor Biopharma Inc
NASDAQ: VOR · HEALTHCARE · BIOTECHNOLOGY
$14.33
+2.14% today
Updated 2026-04-30
Market cap
$702.43M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-70.50
Dividend yield
—
52W range
$3 – $66
Volume
1.1M
Vor Biopharma Inc (VOR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-125.40%
ROA
-70.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-4.15M | — | — | — |
| 2019 | $0.00 | $-10.84M | — | — | — |
| 2020 | $0.00 | $-43.34M | — | — | — |
| 2021 | $0.00 | $-68.90M | — | — | — |
| 2022 | $0.00 | $-92.09M | — | — | — |
| 2023 | $0.00 | $-117.86M | — | — | — |
| 2024 | $0.00 | $-116.91M | — | — | — |
| 2025 | $0.00 | $-695.98M | — | — | — |